The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA4289325
Max Phase: Preclinical
Molecular Formula: C25H25F3N2O4
Molecular Weight: 474.48
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: O=C(O)c1ccc(N2CC3(CCN(Cc4cc(C(F)(F)F)ccc4C4CC4)CC3)OC2=O)cc1
Standard InChI: InChI=1S/C25H25F3N2O4/c26-25(27,28)19-5-8-21(16-1-2-16)18(13-19)14-29-11-9-24(10-12-29)15-30(23(33)34-24)20-6-3-17(4-7-20)22(31)32/h3-8,13,16H,1-2,9-12,14-15H2,(H,31,32)
Standard InChI Key: UNCDRASKFWAOIZ-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 474.48Molecular Weight (Monoisotopic): 474.1766AlogP: 5.27#Rotatable Bonds: 5Polar Surface Area: 70.08Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 4.07CX Basic pKa: 8.14CX LogP: 1.80CX LogD: 1.74Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.64Np Likeness Score: -0.70
References 1. Liu W, Hussain Z, Zang Y, Sweis RF, Romero FA, Finke PE, Moningka R, Bao J, Plotkin MA, Shang J, Dingley KH, Salituro G, Murphy BA, Howard AD, Ujjainwalla F, Wood HB, Duffy JL.. (2018) Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective Antagonists., 9 (11): [PMID:30429950 ] [10.1021/acsmedchemlett.8b00306 ]